Canada markets closed

CK Life Sciences Int'l., (Holdings) Inc. (LSI.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0360-0.0005 (-1.37%)
At close: 08:00AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
5,322,733
5,322,733
5,275,590
5,402,312
4,942,544
Cost of Revenue
3,685,525
3,685,525
3,649,604
3,772,342
3,535,638
Gross Profit
1,637,208
1,637,208
1,625,986
1,629,970
1,406,906
Operating Expenses
Selling General and Administrative
134,976
134,976
138,074
162,287
-
Total Operating Expenses
1,413,360
1,413,360
1,383,901
1,388,843
1,322,153
Operating Income or Loss
223,848
223,848
242,085
241,127
84,753
Interest Expense
322,425
322,425
163,092
97,823
128,726
Income Before Tax
68,584
68,584
204,864
238,239
119,126
Income Tax Expense
51,334
51,334
72,912
75,438
-6,102
Income from Continuing Operations
17,250
17,250
131,952
162,801
125,228
Net Income
17,250
17,250
131,963
162,801
125,234
Net Income available to common shareholders
17,250
17,250
131,963
162,801
125,234
Basic EPS
0.01
0.00
0.01
0.02
0.01
Diluted EPS
0.01
0.00
0.01
0.02
0.01
Basic Average Shares
9,611,073
9,611,073
9,611,073
9,611,073
9,611,073
Diluted Average Shares
9,611,073
9,611,073
9,611,073
9,611,073
9,611,073